Clinical Trial Update: Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated whether vigabatrin can prevent epilepsy in infants with tuberous sclerosis complex; the study results were posted on 2024-08-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberous Sclerosis Complex

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

Sponsor: Martina Bebin | Conditions: Tuberous Sclerosis Complex | Phase 2 | Status: COMPLETED | Results posted: 2024-08-19